Search Results ; , AZITHROMYCIN, Zithromax (Not a Benefit) 200mg/5mL O/L-37.5mL Pk, PFI, N/A ; , AZITHROMYCIN, AG-Azithromycin 250mg Tab, ANG
Search Results ; , AZITHROMYCIN, Auro-Azithromycin 100mg/5mL O/L-15mL Pk ; , AZITHROMYCIN, Auro-Azithromycin 200mg/5mL O/L-15mL Pk ;
Search Results ; , AZITHROMYCIN, Auro-Azithromycin 200mg/5mL O/L-22.5mL Pk, AUR, 18.7425 ; , AZITHROMYCIN, Auro-Azithromycin 200mg/5mL O/L-37.5mL
by F Naqvi 2024Conclusion It is concluded that of low dose azithromycin is as efficacious as rifampicin for treatment of recurrent furunculosis. pk/index.php
cimetidine, given 2 hours before azithromycin, on the pharmacokinetics of azithromycin, no PK/PD relationship: For azithromycin the AUC/MIC is the major PK/PD
(PK) profile for selected derivatives in rodents in comparison to azithromycin. Azithromycin and seven selected 15-membered macrolide derivatives, modified
by CD Rothermel 2024 Cited by 38The pharmacokinetic (PK) and pharmacodynamic (PD) properties of the azalide azithromycin distinguish it from other antibiotics. The PK profile of
by MD MsD .1.4 Azithromycin PK/PD 4.1.4 Azithromycin PK/PD. Table 12a. AUC0-24h/MIC90 ratios of azithromycin calculated for an MIC value of 0.125 µg/mL
Search Results ; , AZITHROMYCIN, Zithromax (Not a Benefit) 200mg/5mL O/L-37.5mL Pk, PFI, N/A ; , AZITHROMYCIN, Zithromax 250mg Tab, PFI, 5.4382
Comments
pk